|
The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes
|
Feb 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
The complex pathophysiology of acquired aplastic anemia
|
Feb 2015
|
Clin Exp Immunol
|
aplastic anemia
|
|
The diagnosis and treatment of aplastic anemia: a review
|
Apr 2015
|
Int J Hematol
|
aplastic anemia
|
|
The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes
|
Jan 2012
|
PLoS One
|
myelodysplastic syndromes (MDS)
|
|
The difficulty to define progression patterns in patients with early stage myelodysplastic syndromes and deletion 5q-New prognostic markers are needed
|
Dec 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
The dysfunction of platelets in paroxysmal nocturnal hemoglobinuria
|
Jul 2016
|
Thromb Res
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
The Effect of Decitabine Dose Modification and Myelosuppression on Response and Survival in Patients With Myelodysplastic Syndromes
|
May 2014
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
The Efficacy of Current Prognostic Models in Predicting Outcome of Patients with Myelodysplastic Syndromes at the Time of Hypomethylating Agent Failure
|
Mar 2016
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
The Evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes.
|
Mar 2013
|
Hematology
|
myelodysplastic syndromes (MDS)
|
|
The evolution of epigenetic therapy in myelodysplastic syndromes and acute myeloid leukemia
|
Jan 2021
|
Seminars in Hematology
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
